EXOZYMES INC (EXOZ) Stock Price, Forecast & Analysis

NASDAQ:EXOZ • US4618741098

10 USD
0 (0%)
Last: Feb 12, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

EXOZ Key Statistics, Chart & Performance

Key Statistics
Market Cap83.90M
Revenue(TTM)N/A
Net Income(TTM)-8.34M
Shares8.39M
Float2.37M
52 Week High21.99
52 Week Low8.86
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-1.76
PEN/A
Fwd PEN/A
Earnings (Next)03-31
IPO2024-11-13
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
EXOZ short term performance overview.The bars show the price performance of EXOZ in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

EXOZ long term performance overview.The bars show the price performance of EXOZ in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of EXOZ is 10 USD. In the past month the price increased by 5.37%. In the past year, price decreased by -48.51%.

EXOZYMES INC / EXOZ Daily stock chart

EXOZ Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to EXOZ. When comparing the yearly performance of all stocks, EXOZ is a bad performer in the overall market: 91.85% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
EXOZ Full Technical Analysis Report

EXOZ Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to EXOZ. The financial health of EXOZ is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
EXOZ Full Fundamental Analysis Report

EXOZ Financial Highlights

Over the last trailing twelve months EXOZ reported a non-GAAP Earnings per Share(EPS) of -1.76. The EPS decreased by -256.1% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -108.04%
ROE -155.17%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%-33.81%
Sales Q2Q%N/A
EPS 1Y (TTM)-256.1%
Revenue 1Y (TTM)N/A
EXOZ financials

EXOZ Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
EXOZ Analyst EstimatesEXOZ Analyst Ratings

EXOZ Ownership

Ownership
Inst Owners0.71%
Ins Owners24.86%
Short Float %0.42%
Short Ratio2.54
EXOZ Ownership

EXOZ Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABBV ABBVIE INC15.67402.079B
AMGN AMGEN INC16.25197.191B
GILD GILEAD SCIENCES INC17.02188.348B
VRTX VERTEX PHARMACEUTICALS INC22.81117.985B
REGN REGENERON PHARMACEUTICALS16.8782.362B
ALNY ALNYLAM PHARMACEUTICALS INC46.0540.753B
INSM INSMED INC N/A31.174B
BIIB BIOGEN INC12.8528.692B
NTRA NATERA INC N/A28.683B
UTHR UNITED THERAPEUTICS CORP16.1620.502B

Related stock screener links

View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges

About EXOZ

Company Profile

EXOZ logo image eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.

Company Info

EXOZYMES INC

750 Royal Oaks Dr

Monrovia California CALIFORNIA US

Employees: 31

EXOZ Company Website

Phone: 16264151488

EXOZYMES INC / EXOZ FAQ

What does EXOZYMES INC do?

eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.


What is the stock price of EXOZYMES INC today?

The current stock price of EXOZ is 10 USD.


Does EXOZ stock pay dividends?

EXOZ does not pay a dividend.


How is the ChartMill rating for EXOZYMES INC?

EXOZ has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Should I buy EXOZ stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on EXOZ.


What is the employee count for EXOZ stock?

EXOZYMES INC (EXOZ) currently has 31 employees.


What is the market capitalization of EXOZ stock?

EXOZYMES INC (EXOZ) has a market capitalization of 83.90M USD. This makes EXOZ a Micro Cap stock.